Advisory Committee for Injury Prevention and Control (ACIPC), Science and Program Review Subcommittee, 41080 [E7-14430]
Download as PDF
41080
Federal Register / Vol. 72, No. 143 / Thursday, July 26, 2007 / Notices
There are no costs to respondents
except their time to participate in the
survey.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hrs.)
Total burden
(in hours)
Respondents
Form name
Grantees ...........................................
Annual Application ...........................
Annual Report ..................................
61
61
1
1
25
30
1525
1830
Total ...........................................
...........................................................
........................
........................
........................
3355
Dated: July 20, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–14439 Filed 7–25–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee for Injury
Prevention and Control (ACIPC),
Science and Program Review
Subcommittee
rwilkins on PROD1PC63 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces, the following meeting for
the aforementioned committee and
subcommittee:
Name: Science and Program Review
Subcommittee (SPRS).
Times and Date: 11:30 a.m.–11:35 a.m.,
August 20, 2007 (Open). 11:35 a.m.–12:30
p.m., August 20, 2007 (Closed).
Place: CDC, Koger Center, Vanderbilt
Building, Room 1006, 2939 Flowers Road,
Atlanta, Georgia 30341–3724.
Purpose: The subcommittee provides
advice on the needs, structure, progress, and
performance of programs in the National
Center for Injury Prevention and Control
(NCIPC).
Matters To Be Discussed: The
subcommittee will have a secondary review,
discussion, and evaluation on the individual
research grant and cooperative agreement
applications submitted in response to the two
Fiscal Year 2007 Requests for Applications
(RFAs) related to the following individual
research announcements: RFA–CE–05–020,
Youth Violence Prevention through
Community-Level Change; and RFA–CE–07–
011, Multi-Level Parent Training
Effectiveness Trial—Phase II (U49).
Following this meeting, the voting
members of ACIPC will meet via
teleconference to vote on the
recommendations of the SPRS regarding the
RFAs.
VerDate Aug<31>2005
16:36 Jul 25, 2007
Jkt 211001
Name: Advisory Committee for Injury
Prevention and Control.
Times and Date: 12:30 p.m.–12:55 p.m.,
August 20, 2007 (Open). 12:55 p.m.–1:30
p.m., August 20, 2007 (Closed).
Place: CDC, Koger Center, Vanderbilt
Building, Room 1006, 2939 Flowers Road,
Atlanta, Georgia 30341–3724.
Purpose: The committee advises and makes
recommendations to the Secretary,
Department of Health and Human Services,
the Director, CDC, and the Director, NCIPC
regarding feasible goals for the prevention
and control of injury. The committee makes
recommendations regarding policies,
strategies, objectives, and priorities, and
reviews progress toward injury prevention
and control.
Matters To Be Discussed: Agenda items for
the open portion include the call to order and
introductions and request for public
comments. The committee will vote on the
results of the secondary review. This portion
of the meeting will be closed to the public
in accordance with the provisions set forth in
section 552b(c)(4) and (b), title 5 U.S.C., and
the Determination of the Acting Director,
Management Analysis and Services Office,
CDC pursuant to Public Law 92–463.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Ms. Amy
Harris, Executive Secretary, ACIPC, NCIPC,
CDC, 4770 Buford Highway, NE., M/S K61,
Atlanta, Georgia 30341–3724, Telephone
(770) 488–4936.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 17, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–14430 Filed 7–25–07; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007D–0290]
Draft Guidance for Industry: Cell
Selection Devices for Point of Care
Production of Minimally Manipulated
Autologous Peripheral Blood Stem
Cells; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft document entitled
‘‘Guidance for Industry: Cell Selection
Devices for Point of Care Production of
Minimally Manipulated Autologous
Peripheral Blood Stem Cells (PBSCs)’’
dated July 2007. The draft guidance
document discusses certain cell
selection devices that minimally
manipulate autologous PBSCs at the
point of care for specific clinical
indications, and the applicability of the
requirements to such PBSCs. The
guidance also discusses the submission
of data intended to support approval of
cell selection devices.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance submit
written or electronic comments on the
draft guidance by October 24, 2007.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Office of Communication, Training, and
Manufacturers Assistance (HFM–40),
Center for Biologics Evaluation and
Research (CBER), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852–1448.
Send one self-addressed adhesive label
to assist the office in processing your
requests. The draft guidance may also be
obtained by mail by calling CBER at 1–
E:\FR\FM\26JYN1.SGM
26JYN1
Agencies
[Federal Register Volume 72, Number 143 (Thursday, July 26, 2007)]
[Notices]
[Page 41080]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-14430]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee for Injury Prevention and Control (ACIPC),
Science and Program Review Subcommittee
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces, the following meeting for the
aforementioned committee and subcommittee:
Name: Science and Program Review Subcommittee (SPRS).
Times and Date: 11:30 a.m.-11:35 a.m., August 20, 2007 (Open).
11:35 a.m.-12:30 p.m., August 20, 2007 (Closed).
Place: CDC, Koger Center, Vanderbilt Building, Room 1006, 2939
Flowers Road, Atlanta, Georgia 30341-3724.
Purpose: The subcommittee provides advice on the needs,
structure, progress, and performance of programs in the National
Center for Injury Prevention and Control (NCIPC).
Matters To Be Discussed: The subcommittee will have a secondary
review, discussion, and evaluation on the individual research grant
and cooperative agreement applications submitted in response to the
two Fiscal Year 2007 Requests for Applications (RFAs) related to the
following individual research announcements: RFA-CE-05-020, Youth
Violence Prevention through Community-Level Change; and RFA-CE-07-
011, Multi-Level Parent Training Effectiveness Trial--Phase II
(U49).
Following this meeting, the voting members of ACIPC will meet
via teleconference to vote on the recommendations of the SPRS
regarding the RFAs.
Name: Advisory Committee for Injury Prevention and Control.
Times and Date: 12:30 p.m.-12:55 p.m., August 20, 2007 (Open).
12:55 p.m.-1:30 p.m., August 20, 2007 (Closed).
Place: CDC, Koger Center, Vanderbilt Building, Room 1006, 2939
Flowers Road, Atlanta, Georgia 30341-3724.
Purpose: The committee advises and makes recommendations to the
Secretary, Department of Health and Human Services, the Director,
CDC, and the Director, NCIPC regarding feasible goals for the
prevention and control of injury. The committee makes
recommendations regarding policies, strategies, objectives, and
priorities, and reviews progress toward injury prevention and
control.
Matters To Be Discussed: Agenda items for the open portion
include the call to order and introductions and request for public
comments. The committee will vote on the results of the secondary
review. This portion of the meeting will be closed to the public in
accordance with the provisions set forth in section 552b(c)(4) and
(b), title 5 U.S.C., and the Determination of the Acting Director,
Management Analysis and Services Office, CDC pursuant to Public Law
92-463.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Ms. Amy Harris, Executive
Secretary, ACIPC, NCIPC, CDC, 4770 Buford Highway, NE., M/S K61,
Atlanta, Georgia 30341-3724, Telephone (770) 488-4936.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 17, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-14430 Filed 7-25-07; 8:45 am]
BILLING CODE 4163-18-P